Federal grant · project grant (b)
Single Cell Tri-omics: High Coverage Simultaneous Profiling of Dna, Rna, and Proteins in Single Cells - Abstract Alzheimer's Disease, a Devastating Neurologic Disorder, Accounts for 60-80% of All Dementias, Making the Development of New Technologies for Studying the Disease Crucial. Fluid Discovery Aims to Advance Single-cell Proteomics With a Groundbreaking Product Called Self-assembled Partitioning Proteomics (sap-pm), Which Will Quantify Thousands of Proteins in Hundreds of Thousands of Individual Cells and Can Be Multiplexed With Single Cell Dna and Rna Sequencing. Building on Cutting-edge Work in Microfluidics, Biophysics, and Genomics, Sap- PM Offers a Unique, Rapid, and Cost-effective Method to Overcome Limitations in Protein Coverage and Sensitivity Found in Current Technologies. the Project Comprises Two Aims: (1) Develop Sap-pm for Sensitive, Thousand-plex Analysis of Proteins at the Single Cell Level, and (2) Expand the Capability of Sap-pm to Analyze Brain Nuclei and Simultaneously Capture Mrna, Facilitating Valuable Insights From Primary Human Tissues to Improve Human Health.
Committed
$268,142
Paid out
$227.7K
85%
Committed, not yet paid
$40.5K
15%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…